Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Natural Killer Cell Therapy
1.2 Key Market Segments
1.2.1 Natural Killer Cell Therapy Segment by Type
1.2.2 Natural Killer Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Natural Killer Cell Therapy Market Overview
2.1 Global Natural Killer Cell Therapy Market Size (M USD) Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Natural Killer Cell Therapy Market Competitive Landscape
3.1 Global Natural Killer Cell Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2 Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturers Natural Killer Cell Therapy Sales Sites, Area Served, Service Type
3.4 Natural Killer Cell Therapy Market Competitive Situation and Trends
3.4.1 Natural Killer Cell Therapy Market Concentration Rate
3.4.2 Global 5 and 10 Largest Natural Killer Cell Therapy Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion

4 Natural Killer Cell Therapy Value Chain Analysis
4.1 Natural Killer Cell Therapy Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 The Development and Dynamics of Natural Killer Cell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies

6 Natural Killer Cell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer Cell Therapy Market Size Market Share by Type (2017-2022)
6.3 Global Natural Killer Cell Therapy Sales Growth Rate by Type (2017-2022)

7 Natural Killer Cell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer Cell Therapy Market Size (M USD) by Application (2017-2022)
7.3 Global Natural Killer Cell Therapy Sales Growth Rate by Application (2017-2022)

8 Natural Killer Cell Therapy Market Segmentation by Region
8.1 Global Natural Killer Cell Therapy Market Size by Region
8.1.1 Global Natural Killer Cell Therapy Market Size by Region
8.1.2 Global Natural Killer Cell Therapy Market Share by Region
8.2 North America
8.2.1 North America Natural Killer Cell Therapy Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Natural Killer Cell Therapy Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Natural Killer Cell Therapy Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Natural Killer Cell Therapy Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Natural Killer Cell Therapy Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Nektar Therapeutics
9.1.1 Nektar Therapeutics Natural Killer Cell Therapy Basic Information
9.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Overview
9.1.3 Nektar Therapeutics Natural Killer Cell Therapy Product Market Performance
9.1.4 Nektar Therapeutics Business Overview
9.1.5 Nektar Therapeutics Natural Killer Cell Therapy SWOT Analysis
9.1.6 Nektar Therapeutics Recent Developments
9.2 Innate Pharma SA
9.2.1 Innate Pharma SA Natural Killer Cell Therapy Basic Information
9.2.2 Innate Pharma SA Natural Killer Cell Therapy Product Overview
9.2.3 Innate Pharma SA Natural Killer Cell Therapy Product Market Performance
9.2.4 Innate Pharma SA Business Overview
9.2.5 Innate Pharma SA Natural Killer Cell Therapy SWOT Analysis
9.2.6 Innate Pharma SA Recent Developments
9.3 Affimed
9.3.1 Affimed Natural Killer Cell Therapy Basic Information
9.3.2 Affimed Natural Killer Cell Therapy Product Overview
9.3.3 Affimed Natural Killer Cell Therapy Product Market Performance
9.3.4 Affimed Business Overview
9.3.5 Affimed Natural Killer Cell Therapy SWOT Analysis
9.3.6 Affimed Recent Developments
9.4 Chipscreen Biosciences
9.4.1 Chipscreen Biosciences Natural Killer Cell Therapy Basic Information
9.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Overview
9.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Product Market Performance
9.4.4 Chipscreen Biosciences Business Overview
9.4.5 Chipscreen Biosciences Natural Killer Cell Therapy SWOT Analysis
9.4.6 Chipscreen Biosciences Recent Developments
9.5 Glycostem Therapeutics
9.5.1 Glycostem Therapeutics Natural Killer Cell Therapy Basic Information
9.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Overview
9.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Product Market Performance
9.5.4 Glycostem Therapeutics Business Overview
9.5.5 Glycostem Therapeutics Natural Killer Cell Therapy SWOT Analysis
9.5.6 Glycostem Therapeutics Recent Developments
9.6 Fate Therapeutics
9.6.1 Fate Therapeutics Natural Killer Cell Therapy Basic Information
9.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Overview
9.6.3 Fate Therapeutics Natural Killer Cell Therapy Product Market Performance
9.6.4 Fate Therapeutics Business Overview
9.6.5 Fate Therapeutics Recent Developments
9.7 Dragonfly Therapeutics
9.7.1 Dragonfly Therapeutics Natural Killer Cell Therapy Basic Information
9.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Overview
9.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Product Market Performance
9.7.4 Dragonfly Therapeutics Business Overview
9.7.5 Dragonfly Therapeutics Recent Developments
9.8 Kiadis Pharma
9.8.1 Kiadis Pharma Natural Killer Cell Therapy Basic Information
9.8.2 Kiadis Pharma Natural Killer Cell Therapy Product Overview
9.8.3 Kiadis Pharma Natural Killer Cell Therapy Product Market Performance
9.8.4 Kiadis Pharma Business Overview
9.8.5 Kiadis Pharma Recent Developments
9.9 Nkarta Therapeutics
9.9.1 Nkarta Therapeutics Natural Killer Cell Therapy Basic Information
9.9.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Overview
9.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Product Market Performance
9.9.4 Nkarta Therapeutics Business Overview
9.9.5 Nkarta Therapeutics Recent Developments
9.10 NantKwest
9.10.1 NantKwest Natural Killer Cell Therapy Basic Information
9.10.2 NantKwest Natural Killer Cell Therapy Product Overview
9.10.3 NantKwest Natural Killer Cell Therapy Product Market Performance
9.10.4 NantKwest Business Overview
9.10.5 NantKwest Recent Developments
10 Natural Killer Cell Therapy Regional Market Forecast
10.1 Global Natural Killer Cell Therapy Market Size Forecast
10.2 Global Natural Killer Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Natural Killer Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Natural Killer Cell Therapy Market Size Forecast by Region
10.2.4 South America Natural Killer Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Natural Killer Cell Therapy by Country
11 Market Segmentation & Size Forecast (2023-2028)
11.1 Global Natural Killer Cell Therapy Market Forecast by Type (2023-2028)
11.2 Global Natural Killer Cell Therapy Market Forecast by Application (2023-2028)
12 Conclusion and Key Findings



List of Figures

?LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Natural Killer Cell Therapy Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Natural Killer Cell Therapy Revenue (M USD) by Manufacturers (2017-2022)

Table 6. Global Natural Killer Cell Therapy Revenue Share by Manufacturers (2017-2022)

Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2021)

Table 8. Manufacturers Natural Killer Cell Therapy Sales Sites and Area Served

Table 9. Manufacturers Natural Killer Cell Therapy Service Type

Table 10. Global Natural Killer Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 11. Mergers & Acquisitions, Expansion Plans

Table 12. Value Chain Map of Natural Killer Cell Therapy

Table 13. Midstream Market Analysis

Table 14. Downstream Customer Analysis

Table 15. Key Development Trends

Table 16. Driving Factors

Table 17. Natural Killer Cell Therapy Market Challenges

Table 18. Market Restraints

Table 19. Global Natural Killer Cell Therapy Market Size by Type (M USD)

Table 20. Global Natural Killer Cell Therapy Market Size (M USD) by Type (2017-2022)

Table 21. Global Natural Killer Cell Therapy Market Size Share by Type (2017-2022)

Table 22. Global Natural Killer Cell Therapy Sales Growth Rate by Type (2017-2022)

Table 23. Global Natural Killer Cell Therapy Sales (K Units) by Application

Table 24. Global Natural Killer Cell Therapy Market Size by Application

Table 25. Global Natural Killer Cell Therapy Sales by Application (2017-2022) & (M USD)

Table 26. Global Natural Killer Cell Therapy Market Share by Application (2017-2022)

Table 27. Global Natural Killer Cell Therapy Sales Growth Rate by Application (2017-2022)

Table 28. Global Natural Killer Cell Therapy Market Size by Region (2017-2022) & (M USD)

Table 29. Global Natural Killer Cell Therapy Market Share by Region (2017-2022)

Table 30. North America Natural Killer Cell Therapy Market Size by Country (2017-2022) & (M USD)

Table 31. Europe Natural Killer Cell Therapy Market Size by Country (2017-2022) & (M USD)

Table 32. Asia Pacific Natural Killer Cell Therapy Market Size by Region (2017-2022) & (M USD)

Table 33. South America Natural Killer Cell Therapy Market Size by Country (2017-2022) & (M USD)

Table 34. Middle East and Africa Natural Killer Cell Therapy Market Size by Region (2017-2022) & (M USD)

Table 35. Nektar Therapeutics Natural Killer Cell Therapy Basic Information

Table 36. Nektar Therapeutics Natural Killer Cell Therapy Product Overview

Table 37. Nektar Therapeutics Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 38. Nektar Therapeutics Business Overview

Table 39. Nektar Therapeutics Natural Killer Cell Therapy SWOT Analysis

Table 40. Nektar Therapeutics Recent Developments

Table 41. Innate Pharma SA Natural Killer Cell Therapy Basic Information

Table 42. Innate Pharma SA Natural Killer Cell Therapy Product Overview

Table 43. Innate Pharma SA Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 44. Innate Pharma SA Business Overview

Table 45. Innate Pharma SA Natural Killer Cell Therapy SWOT Analysis

Table 46. Innate Pharma SA Recent Developments

Table 47. Affimed Natural Killer Cell Therapy Basic Information

Table 48. Affimed Natural Killer Cell Therapy Product Overview

Table 49. Affimed Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 50. Affimed Business Overview

Table 51. Affimed Natural Killer Cell Therapy SWOT Analysis

Table 52. Affimed Recent Developments

Table 53. Chipscreen Biosciences Natural Killer Cell Therapy Basic Information

Table 54. Chipscreen Biosciences Natural Killer Cell Therapy Product Overview

Table 55. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 56. Chipscreen Biosciences Business Overview

Table 57. Chipscreen Biosciences Natural Killer Cell Therapy SWOT Analysis

Table 58. Chipscreen Biosciences Recent Developments

Table 59. Glycostem Therapeutics Natural Killer Cell Therapy Basic Information

Table 60. Glycostem Therapeutics Natural Killer Cell Therapy Product Overview

Table 61. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 62. Glycostem Therapeutics Business Overview

Table 63. Glycostem Therapeutics Natural Killer Cell Therapy SWOT Analysis

Table 64. Glycostem Therapeutics Recent Developments

Table 65. Fate Therapeutics Natural Killer Cell Therapy Basic Information

Table 66. Fate Therapeutics Natural Killer Cell Therapy Product Overview

Table 67. Fate Therapeutics Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 68. Fate Therapeutics Business Overview

Table 69. Fate Therapeutics Recent Developments

Table 70. Dragonfly Therapeutics Natural Killer Cell Therapy Basic Information

Table 71. Dragonfly Therapeutics Natural Killer Cell Therapy Product Overview

Table 72. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 73. Dragonfly Therapeutics Business Overview

Table 74. Dragonfly Therapeutics Recent Developments

Table 75. Kiadis Pharma Natural Killer Cell Therapy Basic Information

Table 76. Kiadis Pharma Natural Killer Cell Therapy Product Overview

Table 77. Kiadis Pharma Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 78. Kiadis Pharma Business Overview

Table 79. Kiadis Pharma Recent Developments

Table 80. Nkarta Therapeutics Natural Killer Cell Therapy Basic Information

Table 81. Nkarta Therapeutics Natural Killer Cell Therapy Product Overview

Table 82. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 83. Nkarta Therapeutics Business Overview

Table 84. Nkarta Therapeutics Recent Developments

Table 85. NantKwest Natural Killer Cell Therapy Basic Information

Table 86. NantKwest Natural Killer Cell Therapy Product Overview

Table 87. NantKwest Natural Killer Cell Therapy Revenue (M USD) and Gross Margin (2017-2022)

Table 88. NantKwest Business Overview

Table 89. NantKwest Recent Developments

Table 90. Global Natural Killer Cell Therapy Market Size Forecast by Region (M USD)

Table 91. North America Natural Killer Cell Therapy Market Size Forecast by Country (2023-2028) & (M USD)

Table 92. Europe Natural Killer Cell Therapy Market Size Forecast by Country (2023-2028) & (M USD)

Table 93. Asia Pacific Natural Killer Cell Therapy Market Size Forecast by Region (2023-2028) & (M USD)

Table 94. South America Natural Killer Cell Therapy Market Size Forecast by Country (2023-2028) & (M USD)

Table 95. Middle East and Africa Natural Killer Cell Therapy Market Size Forecast by Country (2023-2028) & (M USD)

Table 96. Global Natural Killer Cell Therapy Market Size Forecast by Type (2023-2028) & (M USD)

Table 97. Global Natural Killer Cell Therapy Market Size Forecast by Application (2023-2028) & (M USD)

List of Figures

Figure 1. Industrial Chain of Natural Killer Cell Therapy

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Natural Killer Cell Therapy Market Size (M USD), 2017-2028

Figure 5. Global Natural Killer Cell Therapy Market Size (M USD) (2017-2028)

Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 8. Evaluation Matrix of Regional Market Development Potential

Figure 9. Natural Killer Cell Therapy Market Size (M USD) by Country (M USD)

Figure 10. Global Natural Killer Cell Therapy Revenue Share by Manufacturers in 2021

Figure 11. Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 12. The Global 5 and 10 Largest Players: Market Share by Natural Killer Cell Therapy Revenue in 2021

Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 14. Global Natural Killer Cell Therapy Market Share by Type

Figure 15. Market Size Share of Natural Killer Cell Therapy by Type (2017-2022)

Figure 16. Market Size Market Share of Natural Killer Cell Therapy by Type in 2021

Figure 17. Global Natural Killer Cell Therapy Sales Growth Rate by Type (2017-2022)

Figure 18. Global Natural Killer Cell Therapy Market Share by Application

Figure 19. Global Natural Killer Cell Therapy Market Share by Application (2017-2022)

Figure 20. Global Natural Killer Cell Therapy Market Share by Application in 2021

Figure 21. Global Natural Killer Cell Therapy Sales Growth Rate by Application (2017-2022)

Figure 22. Global Natural Killer Cell Therapy Market Share by Region (2017-2022)

Figure 23. North America Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 24. North America Natural Killer Cell Therapy Market Share by Country in 2021

Figure 25. U.S. Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 26. Canada Natural Killer Cell Therapy Market Size (M USD) and Growth Rate (2017-2022)

Figure 27. Mexico Natural Killer Cell Therapy Market Size (Units) and Growth Rate (2017-2022)

Figure 28. Europe Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 29. Europe Natural Killer Cell Therapy Market Share by Country in 2021

Figure 30. Germany Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 31. France Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 32. U.K. Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 33. Italy Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 34. Russia Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 35. Asia Pacific Natural Killer Cell Therapy Market Size and Growth Rate (M USD)

Figure 36. Asia Pacific Natural Killer Cell Therapy Market Share by Region in 2021

Figure 37. China Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 38. Japan Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 39. South Korea Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 40. India Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 41. Southeast Asia Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 42. South America Natural Killer Cell Therapy Market Size and Growth Rate (M USD)

Figure 43. South America Natural Killer Cell Therapy Market Share by Country in 2021

Figure 44. Brazil Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 45. Argentina Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 46. Columbia Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 47. Middle East and Africa Natural Killer Cell Therapy Market Size and Growth Rate (M USD)

Figure 48. Middle East and Africa Natural Killer Cell Therapy Market Share by Region in 2021

Figure 49. Saudi Arabia Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 50. UAE Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 51. Egypt Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 52. Nigeria Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 53. South Africa Natural Killer Cell Therapy Market Size and Growth Rate (2017-2022) & (M USD)

Figure 54. Global Natural Killer Cell Therapy Market Size Forecast by Value (2017-2028) & (M USD)

Figure 55. Global Natural Killer Cell Therapy Market Share Forecast by Type (2023-2028)

Figure 56. Global Natural Killer Cell Therapy Market Share Forecast by Application (2023-2028)